Mild depression affects HCV treatment success, study says

09/9/2011 | Medscape (free registration)

Mildly depressed patients with hepatitis C virus who begin interferon-based antiviral therapy could see their depression symptoms worsen, which may make it more likely they will discontinue treatment, researchers reported in the American Journal of Gastroenterology. The study team from the Veterans Affairs Palo Alto Health Care System and Stanford University also found that 53% of minimally depressed patients did not achieve a sustained virologic response to treatment, compared with those who were mildly or moderately depressed. Read the abstract.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC